Skip to main content

Closed

PEN: Penumbra, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+12.9% / yr

Operating margin12.4%

ROIC8.4%

Financially safe

Strong

Debt / equity0.14×

Interest coverage279.2×

Current ratio5.75×

Valuation

Unrated

P/E ratio78.5×

Penumbra, Inc.

PENNew York Stock Exchange·USD·Closed

Penumbra, Inc.

PENNew York Stock Exchange·USD·Closed

$321.19

+0.43%

$321.19

+$1.36 (0.43%)

52W Range

71thpctl

Volume

0.59×avg

Mkt Cap

12.63BUSD

P/E

78.5TTM

Div Yield

–ann

52W Range

71thpctl

Volume

0.59×avg

Market Cap

12.63BUSD

P/E Ratio

78.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings